Chris is a Senior News Writer for Collider. He can be found in an IMAX screen, with his eyes watering and his ears bleeding for his own pleasure. He joined the news team in 2022 and accidentally fell ...

– New EDGE-Gastric Overall Survival Results, for Anti-TIGIT Domvanalimab plus Anti-PD-1 Zimberelimab and Chemotherapy also to be Presented – FOSTER CITY, Calif., October 13, 2025--(BUSINESS ...

KITE & KEY MEDIA: We’re living in a golden age of knowledge — so why is it harder than ever to separate fact from fiction? A recent study estimated that a typical person today processes about 74 ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Bertjan Pot, Liesbeth Abbenes and Maurice Scheltens are gathered in The Hague’s Museum Voorlinden after hours.

After years of demands from shareholders for another major deal, Gilead has made a spectacular move, sealing a deal to acquire cell therapy leader Kite for just under $12 billion. Gilead had been the ...

Gilead’s $11.9 billion purchase of Kite Pharma in 2017 didn’t follow the script, with two big write-downs in the value of the asset since then, but a fresh approval for a CAR-T therapy could claw back ...

A Texas man wearing a Jason-style hockey mask allegedly opened fire on a Dallas bus after a dispute with another man, shooting him nine times with a Draco AK-47. Harrington Hurdle, 27, stands accused ...